Anti-BCAS1 / NABC1 Antibody (34017)
Data
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Rabbit Immunogen Synthetic peptide corresponding to amino acids 532-550 of human BCAS1/NABC1. Product Concentration Lot Specific Formulation PBS, pH 7.4. State of Matter Liquid Product Preparation Purified by immunoaffinity chromatography Storage and Handling This antibody is stable for at least one (1) year at -20°C. Avoid multiple freeze- thaw cycles. Country of Origin USA Shipping Next Day 2-8°C Applications and Recommended Usage? Quality Tested by Leinco Immunoblotting : use at 1-5ug/mL.A band of approximately 60kDa is detected, however, protein dimerization may occur.
These are recommended concentrations. User should determine optimal concentrations for their applications. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionDescriptionSpecificity Rabbit Polyclonal Antibody specific to BCAS1/NABC1 Background Breast Carcinoma Amplified Sequence 1 (BCAS1), also known as Novel Amplified in Breast Cancer 1 (NABC1) was isolated from a region at 20q13 and is amplified in several tumor types. It is associated with more aggressive tumor phenotypes. BCAS1/NABC1 is highly expressed in some, but not all, breast cancer cell lines and in some breast tumors at 20q13.2. The BCAS1/NABC1 gene is predicted to encode a protein of 584 amino acids with no significant homology to other proteins. Function Required for myelination. {UniProtKB:Q80YN3}. NCBI Gene Bank ID UniProt.org Research Area Cancer Research References & CitationsChang, N.S et al. Oncogene (2005) 24: 714-723. Aqeilan, R.I. et al. Cancer Res (2004) 64: 8256-8261. Sze, C.I. et al. J Biol Chem (2004) 279: 30498-30506. Technical ProtocolsCertificate of Analysis |
